Please login to the form below

Not currently logged in

oral antiviral treatment

This page shows the latest oral antiviral treatment news and features for those working in and with pharma, biotech and healthcare.

Keytruda growth helps Merck to offset COVID-19 impact in Q3

Keytruda growth helps Merck to offset COVID-19 impact in Q3

Merck is currently developing an oral antiviral candidate for the treatment of COVID-19, as well as two vaccine candidates for the novel coronavirus – V591 and V950.

Latest news

More from news
Approximately 0 fully matching, plus 3 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs


Add my company
Page & Page and Partners

For those who can imagine better, Page & Page and Partners (P&P) is home to meaningful encounters of a marketing, communication...

Latest intelligence

What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Securing a future for telehealth with immersive market research insights...
Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...